The signaling cascade of ERBB2 is mediated by kinases and as such the resistance to anti-ERBB2 is concomitant with the increased activity of kinase that helps the drug-resistant cancers to proliferate and metastasize. The gene discussed is ERBB2; the disease is cancer.